Product
Omega-3 polyunsaturated fatty acids
1 clinical trial
1 indication
Indication
SchizophreniaClinical trial
Clinical Comprehensive Intervention on Cognitive Impairment of Schizophrenia Patients With Metabolic SyndromeStatus: , Estimated PCD: 2024-11-01